BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 2
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8256)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.
Item 
Count 
PDF311
WORD40
HTML4902
Figures (1-7)755
Tables (1-2)423
 Sum=6431
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse204
Download478
 Sum=682
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse262
Download881
 Sum=1143
Jan 14, 2023 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: de Moraes Andrade PV, Monteiro YM, Chehter EZ. Third-line and rescue therapy for refractory Helicobacter pylori infection: A systematic review. World J Gastroenterol 2023; 29(2): 390-409 [PMID: 36687120 DOI: 10.3748/wjg.v29.i2.390]
URL: https://www.wjgnet.com/1007-9327/full/v29/i2/390.htm
Number Citing Articles
1
Maria Belen Justich, Olga L. Rojas, Alfonso Fasano. The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease. Seminars in Neurology 2023; 43(04): 553 doi: 10.1055/s-0043-1771468
2
Belén Martínez Benito, Olga P. Nyssen, Javier P. Gisbert. Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis. Helicobacter 2024; 29(6) doi: 10.1111/hel.13148
3
Chia-Jung Kuo, Ngoc-Niem Bui, Jun-Nong Ke, Cheng-Yu Lin, Wey-Ran Lin, Ming-Ling Chang, Hui-Yu Wu, Mei-Zi Huang, Cheng-Hsun Chiu, Cheng-Tang Chiu, Chih-Ho Lai. Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan. International Journal of Infectious Diseases 2024; 138: 25 doi: 10.1016/j.ijid.2023.11.001
4
William D. Chey, Colin W. Howden, Steven F. Moss, Douglas R. Morgan, Katarina B. Greer, Shilpa Grover, Shailja C. Shah. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2024; 119(9): 1730 doi: 10.14309/ajg.0000000000002968
5
Joseph Edwin Kanu, Jonathan Soldera. Treatment of <i>Helicobacter pylori</i> with potassium competitive acid blockers: A systematic review and meta-analysis. World Journal of Gastroenterology 2024; 30(9): 1213-1223 doi: 10.3748/wjg.v30.i9.1213
6
Claudiu T. Supuran. Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection . Expert Opinion on Investigational Drugs 2024; 33(5): 523 doi: 10.1080/13543784.2024.2334714
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345